SDGR
Schrödinger, Inc.$12.17+0.43 (+3.66%)Prev Close$11.74·MCap$870.4M·P/E—·Vol1.16M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
17
$1.33M
◆
Net Activity
Net Seller
$1.33M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Schrödinger, Inc. (SDGR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 17 insider sales totaling $1.33M. The most recent insider transaction was by Jain Rachit (officer: EVP & CFO), who sold $10.8K worth of shares on Apr 17, 2026. Schrödinger, Inc. operates in the Healthcare sector, within the Medical - Healthcare Information Services industry, with a market cap of $870.4M.
SDGR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Jain Rachit | officer: EVP & CFO | Sell | 844 | $12.75 | $10.8K | 51,752 |
| Apr 17, 2026 | Farid Ramy | director, officer: President & CEO | Sell | 86,000 | $12.27 | $1.06M | 330,824 |
| Mar 6, 2026 | Farid Ramy | director, officer: President & CEO | Sell | 3,661 | $12.91 | $47.2K | 330,824 |
| Mar 6, 2026 | Herman Jenny | officer: CAO | Sell | 1,383 | $12.84 | $17.8K | 35,412 |
| Mar 6, 2026 | Jain Rachit | officer: EVP & CFO | Sell | 1,631 | $12.90 | $21.0K | 52,596 |
| Mar 6, 2026 | Lorton Kenneth Patrick | officer: EVP, CTO & COO, Software | Sell | 1,222 | $12.90 | $15.8K | 89,241 |
| Mar 6, 2026 | Tran Yvonne | officer: EVP, CLO & CPO | Sell | 1,094 | $12.89 | $14.1K | 52,683 |
| Mar 6, 2026 | Abel Robert Lorne | officer: See Remarks | Sell | 1,300 | $12.81 | $16.7K | 55,897 |
| Mar 6, 2026 | Akinsanya Karen | officer: See Remarks | Sell | 1,366 | $12.90 | $17.6K | 69,956 |
| Feb 12, 2026 | Herman Jenny | officer: CAO | Sell | 752 | $13.79 | $10.4K | 26,597 |
| Feb 12, 2026 | Lorton Kenneth Patrick | officer: EVP, CTO & COO, Software | Sell | 925 | $13.73 | $12.7K | 52,651 |
| Feb 12, 2026 | Tran Yvonne | officer: EVP, CLO & CPO | Sell | 776 | $13.80 | $10.7K | 22,859 |
| Feb 10, 2026 | Herman Jenny | CAO | Sell | 752 | $13.79 | $10.4K | 0 |
| Feb 10, 2026 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Sell | 925 | $13.73 | $12.7K | 0 |
| Feb 10, 2026 | Tran Yvonne | EVP, CLO & CPO | Sell | 776 | $13.80 | $10.7K | 0 |
| Feb 9, 2026 | Abel Robert Lorne | See Remarks | Sell | 1,230 | $13.51 | $16.6K | 0 |
| Oct 16, 2025 | Dugan Margaret | Chief Medical Officer | Sell | 1,395 | $21.07 | $29.4K | 0 |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Sell | 16,723 | $25.09 | $419.6K | 0 |
| Mar 6, 2025 | Herman Jenny | SVP & Controller | Sell | 666 | $21.11 | $14.1K | 0 |
| Mar 3, 2025 | Porges Geoffrey Craig | EVP & CFO | Sell | 5,491 | $21.76 | $119.5K | 0 |
| Feb 19, 2025 | Tran Yvonne | EVP, CLO & CPO | Sell | 3,902 | $28.00 | $109.3K | 11,135-26% |
| Feb 12, 2025 | Abel Robert Lorne | See Remarks | Sell | 1,225 | $25.99 | $31.8K | 8,115 |
| Feb 12, 2025 | Herman Jenny | SVP & Controller | Sell | 859 | $24.43 | $21.0K | 18,215 |
| Feb 12, 2025 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Sell | 985 | $24.43 | $24.1K | 41,076 |
| Feb 12, 2025 | Tran Yvonne | EVP, CLO & CPO | Sell | 828 | $24.43 | $20.2K | 11,135 |
| Oct 16, 2024 | Dugan Margaret | Chief Medical Officer | Sell | 1,531 | $17.78 | $27.2K | 13,469 |
| Mar 5, 2024 | Porges Geoffrey Craig | EVP & CFO | Sell | 3,315 | $26.35 | $87.4K | 5,685-37% |
| Feb 13, 2024 | Abel Robert Lorne | See Remarks | Sell | 1,205 | $27.55 | $33.2K | 9,340 |
| Feb 13, 2024 | Herman Jenny | SVP & Controller | Sell | 787 | $28.29 | $22.3K | 11,761 |
| Feb 13, 2024 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Sell | 901 | $28.29 | $25.5K | 36,487 |
| Feb 13, 2024 | Tran Yvonne | EVP, CLO & CPO | Sell | 758 | $28.29 | $21.4K | 11,963 |
| Aug 10, 2023 | Lorton Kenneth Patrick | EVP & Chief Technology Officer | Sell | 10,000 | $40.06 | $400.6K | 37,388 |
| Jul 3, 2023 | Tran Yvonne | EVP, CLO & CPO | Sell | 12,040 | $50.00 | $602.0K | 12,721-49% |
| May 24, 2023 | Lorton Kenneth Patrick | EVP & Chief Technology Officer | Sell | 10,000 | $40.06 | $400.6K | 47,388 |
| May 24, 2023 | Tran Yvonne | EVP, CLO & CPO | Sell | 22,960 | $36.76 | $844.1K | 12,721-64% |
| May 23, 2023 | Thornberry Nancy | Director | Sell | 14,850 | $35.00 | $519.8K | 0Exit |
| Feb 3, 2023 | Tran Yvonne | EVP & Chief Legal Officer | Sell | 25,000 | $27.26 | $681.4K | 5,131-83% |
| Jan 5, 2023 | Farid Ramy | President & CEO | Sell | 66,886 | $18.28 | $1.22M | 184,432-27% |
| Aug 12, 2022 | Thornberry Nancy | Director | Sell | 4,950 | $35.00 | $173.3K | 0Exit |
| Dec 14, 2021 | Abel Robert Lorne | See Remarks | Sell | 15,601 | $36.28 | $566.0K | 1,900-89% |
| Oct 19, 2021 | Akinsanya Karen | See Remarks | Sell | 1,393 | $55.75 | $77.7K | 0Exit |
| Sep 16, 2021 | Akinsanya Karen | See Remarks | Sell | 1,394 | $61.13 | $85.2K | 0Exit |
| Sep 14, 2021 | Abel Robert Lorne | See Remarks | Sell | 15,602 | $61.75 | $963.4K | 9,782-61% |
| Sep 3, 2021 | Lebowitz Joel | EVP & CFO | Sell | 5,574 | $64.60 | $360.1K | 0Exit |
| Aug 17, 2021 | Akinsanya Karen | See Remarks | Sell | 37,738 | $57.75 | $2.18M | 16,047-70% |
| Aug 4, 2021 | Tran Yvonne | EVP & Chief Legal Officer | Sell | 12,000 | $68.17 | $818.0K | 13,181-48% |
| Jul 19, 2021 | SHAW DAVID E | 10% Owner | Sell | 63,061 | $68.07 | $4.29M | 6,164,703 |
| Jul 16, 2021 | Lebowitz Joel | EVP & CFO | Sell | 5,574 | $68.04 | $379.3K | 3,067-65% |
| Jul 16, 2021 | SHAW DAVID E | 10% Owner | Sell | 88,358 | $66.78 | $5.90M | 6,245,181 |
| Jul 14, 2021 | SHAW DAVID E | 10% Owner | Sell | 106,194 | $70.58 | $7.50M | 6,342,108 |
Showing 1–50 of 92
1 / 2
SDGR Insider Buying Activity
The following table shows recent insider purchases of Schrödinger, Inc. (SDGR) stock reported via SEC Form 4 filings.
No insider buying activity found for SDGR in the last 12 months.
SDGR Insider Selling Activity
The following table shows recent insider sales of Schrödinger, Inc. (SDGR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Jain Rachit | officer: EVP & CFO | Sell | 844 | $12.75 | $10.8K | 51,752 |
| Apr 17, 2026 | Farid Ramy | director, officer: President & CEO | Sell | 86,000 | $12.27 | $1.06M | 330,824 |
| Mar 6, 2026 | Farid Ramy | director, officer: President & CEO | Sell | 3,661 | $12.91 | $47.2K | 330,824 |
| Mar 6, 2026 | Herman Jenny | officer: CAO | Sell | 1,383 | $12.84 | $17.8K | 35,412 |
| Mar 6, 2026 | Jain Rachit | officer: EVP & CFO | Sell | 1,631 | $12.90 | $21.0K | 52,596 |
| Mar 6, 2026 | Lorton Kenneth Patrick | officer: EVP, CTO & COO, Software | Sell | 1,222 | $12.90 | $15.8K | 89,241 |
| Mar 6, 2026 | Tran Yvonne | officer: EVP, CLO & CPO | Sell | 1,094 | $12.89 | $14.1K | 52,683 |
| Mar 6, 2026 | Abel Robert Lorne | officer: See Remarks | Sell | 1,300 | $12.81 | $16.7K | 55,897 |
| Mar 6, 2026 | Akinsanya Karen | officer: See Remarks | Sell | 1,366 | $12.90 | $17.6K | 69,956 |
| Feb 12, 2026 | Herman Jenny | officer: CAO | Sell | 752 | $13.79 | $10.4K | 26,597 |
| Feb 12, 2026 | Lorton Kenneth Patrick | officer: EVP, CTO & COO, Software | Sell | 925 | $13.73 | $12.7K | 52,651 |
| Feb 12, 2026 | Tran Yvonne | officer: EVP, CLO & CPO | Sell | 776 | $13.80 | $10.7K | 22,859 |
| Feb 10, 2026 | Herman Jenny | CAO | Sell | 752 | $13.79 | $10.4K | 0 |
| Feb 10, 2026 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Sell | 925 | $13.73 | $12.7K | 0 |
| Feb 10, 2026 | Tran Yvonne | EVP, CLO & CPO | Sell | 776 | $13.80 | $10.7K | 0 |
| Feb 9, 2026 | Abel Robert Lorne | See Remarks | Sell | 1,230 | $13.51 | $16.6K | 0 |
| Oct 16, 2025 | Dugan Margaret | Chief Medical Officer | Sell | 1,395 | $21.07 | $29.4K | 0 |
| Apr 14, 2025 | Akinsanya Karen | President of R&D, Therapeutics | Sell | 16,723 | $25.09 | $419.6K | 0 |
| Mar 6, 2025 | Herman Jenny | SVP & Controller | Sell | 666 | $21.11 | $14.1K | 0 |
| Mar 3, 2025 | Porges Geoffrey Craig | EVP & CFO | Sell | 5,491 | $21.76 | $119.5K | 0 |
| Feb 19, 2025 | Tran Yvonne | EVP, CLO & CPO | Sell | 3,902 | $28.00 | $109.3K | 11,135-26% |
| Feb 12, 2025 | Abel Robert Lorne | See Remarks | Sell | 1,225 | $25.99 | $31.8K | 8,115 |
| Feb 12, 2025 | Herman Jenny | SVP & Controller | Sell | 859 | $24.43 | $21.0K | 18,215 |
| Feb 12, 2025 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Sell | 985 | $24.43 | $24.1K | 41,076 |
| Feb 12, 2025 | Tran Yvonne | EVP, CLO & CPO | Sell | 828 | $24.43 | $20.2K | 11,135 |
| Oct 16, 2024 | Dugan Margaret | Chief Medical Officer | Sell | 1,531 | $17.78 | $27.2K | 13,469 |
| Mar 5, 2024 | Porges Geoffrey Craig | EVP & CFO | Sell | 3,315 | $26.35 | $87.4K | 5,685-37% |
| Feb 13, 2024 | Abel Robert Lorne | See Remarks | Sell | 1,205 | $27.55 | $33.2K | 9,340 |
| Feb 13, 2024 | Herman Jenny | SVP & Controller | Sell | 787 | $28.29 | $22.3K | 11,761 |
| Feb 13, 2024 | Lorton Kenneth Patrick | EVP, CTO & COO, Software | Sell | 901 | $28.29 | $25.5K | 36,487 |
| Feb 13, 2024 | Tran Yvonne | EVP, CLO & CPO | Sell | 758 | $28.29 | $21.4K | 11,963 |
| Aug 10, 2023 | Lorton Kenneth Patrick | EVP & Chief Technology Officer | Sell | 10,000 | $40.06 | $400.6K | 37,388 |
| Jul 3, 2023 | Tran Yvonne | EVP, CLO & CPO | Sell | 12,040 | $50.00 | $602.0K | 12,721-49% |
| May 24, 2023 | Lorton Kenneth Patrick | EVP & Chief Technology Officer | Sell | 10,000 | $40.06 | $400.6K | 47,388 |
| May 24, 2023 | Tran Yvonne | EVP, CLO & CPO | Sell | 22,960 | $36.76 | $844.1K | 12,721-64% |
| May 23, 2023 | Thornberry Nancy | Director | Sell | 14,850 | $35.00 | $519.8K | 0Exit |
| Feb 3, 2023 | Tran Yvonne | EVP & Chief Legal Officer | Sell | 25,000 | $27.26 | $681.4K | 5,131-83% |
| Jan 5, 2023 | Farid Ramy | President & CEO | Sell | 66,886 | $18.28 | $1.22M | 184,432-27% |
| Aug 12, 2022 | Thornberry Nancy | Director | Sell | 4,950 | $35.00 | $173.3K | 0Exit |
| Dec 14, 2021 | Abel Robert Lorne | See Remarks | Sell | 15,601 | $36.28 | $566.0K | 1,900-89% |
| Oct 19, 2021 | Akinsanya Karen | See Remarks | Sell | 1,393 | $55.75 | $77.7K | 0Exit |
| Sep 16, 2021 | Akinsanya Karen | See Remarks | Sell | 1,394 | $61.13 | $85.2K | 0Exit |
| Sep 14, 2021 | Abel Robert Lorne | See Remarks | Sell | 15,602 | $61.75 | $963.4K | 9,782-61% |
| Sep 3, 2021 | Lebowitz Joel | EVP & CFO | Sell | 5,574 | $64.60 | $360.1K | 0Exit |
| Aug 17, 2021 | Akinsanya Karen | See Remarks | Sell | 37,738 | $57.75 | $2.18M | 16,047-70% |
| Aug 4, 2021 | Tran Yvonne | EVP & Chief Legal Officer | Sell | 12,000 | $68.17 | $818.0K | 13,181-48% |
| Jul 19, 2021 | SHAW DAVID E | 10% Owner | Sell | 63,061 | $68.07 | $4.29M | 6,164,703 |
| Jul 16, 2021 | Lebowitz Joel | EVP & CFO | Sell | 5,574 | $68.04 | $379.3K | 3,067-65% |
| Jul 16, 2021 | SHAW DAVID E | 10% Owner | Sell | 88,358 | $66.78 | $5.90M | 6,245,181 |
| Jul 14, 2021 | SHAW DAVID E | 10% Owner | Sell | 106,194 | $70.58 | $7.50M | 6,342,108 |
SDGR Insiders
Similar Stocks to SDGR
GEHC
GE HealthCare Technologies Inc.
$68.93-2.16%
$33.83B
VEEV
Veeva Systems Inc.
$158.86-0.98%
$27.78B
TEM
Tempus AI, Inc.
$51.24-2.70%
$9.68B
BTSG
BrightSpring Health Services, Inc. Common Stock
$47.96-1.31%
$9.13B
DOCS
Doximity, Inc.
$24.78+0.53%
$4.51B
HNGE
Hinge Health, Inc.
$45.01-0.44%
$3.49B
PRVA
Privia Health Group, Inc.
$24.59+0.76%
$2.96B
TXG
10x Genomics, Inc.
$21.56-3.23%
$2.82B